Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Accumulated Depreciation & Amortization (2016 - 2022)

Historic Accumulated Depreciation & Amortization for Aptevo Therapeutics (APVO) over the last 8 years, with Q4 2022 value amounting to $13.0 million.

  • Aptevo Therapeutics' Accumulated Depreciation & Amortization rose 608.36% to $13.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $13.0 million, marking a year-over-year increase of 608.36%. This contributed to the annual value of $13.0 million for FY2022, which is 608.36% up from last year.
  • As of Q4 2022, Aptevo Therapeutics' Accumulated Depreciation & Amortization stood at $13.0 million, which was up 608.36% from $12.3 million recorded in Q4 2021.
  • Aptevo Therapeutics' 5-year Accumulated Depreciation & Amortization high stood at $13.0 million for Q4 2022, and its period low was $8.7 million during Q4 2018.
  • Its 5-year average for Accumulated Depreciation & Amortization is $11.0 million, with a median of $11.1 million in 2020.
  • As far as peak fluctuations go, Aptevo Therapeutics' Accumulated Depreciation & Amortization soared by 1560.34% in 2018, and later skyrocketed by 608.36% in 2022.
  • Quarter analysis of 5 years shows Aptevo Therapeutics' Accumulated Depreciation & Amortization stood at $8.7 million in 2018, then grew by 14.1% to $9.9 million in 2019, then grew by 12.28% to $11.1 million in 2020, then grew by 10.19% to $12.3 million in 2021, then rose by 6.08% to $13.0 million in 2022.
  • Its Accumulated Depreciation & Amortization was $13.0 million in Q4 2022, compared to $12.3 million in Q4 2021 and $11.1 million in Q4 2020.